Company · CIK 0001390478
SELLAS Life Sciences Group, Inc.
SLSSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$11.65+$0.39 (+3.46%)
SLS · Last trade
- Prev close
- $11.26
- Range (30d)
- $11.26 – $13.95
On the record
Recent filings
- 8-KSLSCurrent report0001390478-26-000013 · 229.3 KBSEC(opens sec.gov)
- 10-QSLSQuarterly update0001390478-26-000012 · 4.0 MBSEC(opens sec.gov)
- SCHEDULE 13GSLSSELLAS Life Sciences Group, Inc.0000093751-26-000539 · 8.4 KBSEC(opens sec.gov)
- SCHEDULE 13GSLSSELLAS Life Sciences Group, Inc.0002100119-26-001315 · 7.9 KBSEC(opens sec.gov)
- 8-KSLSCurrent report0001104659-26-087110 · 195.8 KBSEC(opens sec.gov)
- 8-KSLSCurrent report0001104659-26-077556 · 359.5 KBSEC(opens sec.gov)
- 8-KSLSCurrent report0001104659-26-075775 · 198.1 KBSEC(opens sec.gov)
- 8-KSLSCurrent report0001104659-26-069251 · 193.0 KBSEC(opens sec.gov)
- 8-KSLSCurrent report0001390478-26-000009 · 222.5 KBSEC(opens sec.gov)
- 10-QSLSQuarterly update0001390478-26-000008 · 3.7 MBSEC(opens sec.gov)
Insiders
- Ahn Mark JDirector, President & CEO
- Andrikopoulos KonstantinosVP, Legal
- Ashton WilliamDirector
- Beerman Noah DDirector, CEO and President
- Burns John ThomasCFO
- Chin RichardDirector
- CICIC DRAGANSVP, Chief Development Officer
- DiPalma Stephen J.CFO, EVP, Secretary
- Dunlap RyanFormer Chief Financial Officer
- Einhorn Irving M.Director
Tickers
Addresses
business
7 TIMES SQUARE SUITE 2503
NEW YORK, NY, 10036
mailing
7 TIMES SQUARE SUITE 2503
NEW YORK, NY, 10036
Former names
- GALENA BIOPHARMA, INC.2017-12-15
- Galena Biopharma, Inc.2017-12-15
- RXI PHARMACEUTICALS CORP2011-09-21
Same industry